News
Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.
U.S. stocks were trading near session highs Monday afternoon, putting the S&P 500 closer to record territory. The risk-on tone was attributed to a diminished "fear factor" in markets since the U.S.'s ...
S&W Seed terminated all non-essential employees to reduce costs and is considering strategic alternatives potentially including bankruptcy or a dissolution and liquidation of the company. Shares ...
Is the Federal Reserve suddenly open to cutting U.S. interest rates as early as July? That’s what Wall Street investors want ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results